SD Cyber Security
Biotech / Life Sciences

San Diego Biotech Firm Achieves HIPAA Compliance

How a 200-employee biotech company went from zero formal security program to full HIPAA compliance and SOC 2 Type I certification in 90 days -- unlocking three new enterprise partnerships.

90-Day

Timeline to Compliance

SOC 2

Type I Certified

60%

Fewer Security Incidents

3

New Enterprise Partnerships

Background

The client is a San Diego-based biotechnology company specializing in novel therapeutic development for autoimmune diseases. Founded in 2016, the company grew from a 15-person research team to a 200-employee organization with offices in the Torrey Pines corridor and a satellite lab in Sorrento Valley.

As the company matured, its client base shifted from academic research collaborations to enterprise pharmaceutical partnerships. Two major pharma companies expressed interest in licensing agreements and joint research programs, but both required evidence of HIPAA compliance and SOC 2 certification before executing contracts.

The company’s IT infrastructure had been built organically over several years with no formal security architecture. Research data, clinical trial information, and protected health information were stored across multiple systems with inconsistent access controls and no centralized monitoring.

The Challenge

The company faced a critical inflection point. Without HIPAA compliance and SOC 2 certification, the two partnership deals -- worth an estimated $12M in combined contract value -- would fall through. The partnerships had a hard deadline, giving the team just 90 days to build a security program from scratch and achieve both certifications.

The specific challenges included:

No Security Foundation

No written security policies, no designated security personnel, no formal risk assessment ever conducted. The company was starting from zero.

Sensitive Data Exposure

PHI and proprietary research data were stored across cloud platforms, local servers, and individual workstations with no data classification or access controls.

Dual Compliance Requirements

HIPAA and SOC 2 have overlapping but distinct requirements. The program needed to satisfy both frameworks simultaneously under an aggressive timeline.

Research Continuity

Active clinical trials and research programs could not be disrupted. Security implementation had to work around critical research operations.

Our Approach

We designed a five-phase approach that ran parallel workstreams to compress the timeline. Each phase had defined deliverables, milestones, and validation checkpoints to ensure nothing was missed.

1
Discovery & Gap Assessment

Weeks 1-2

We conducted a comprehensive assessment of the company's entire IT environment, data flows, and business processes to identify every gap between current state and HIPAA/SOC 2 requirements.

  • Mapped all systems storing, processing, or transmitting PHI and research data
  • Interviewed department heads to document business processes and data workflows
  • Performed vulnerability scanning across all internal and external-facing systems
  • Reviewed existing IT policies, access controls, and vendor agreements
  • Identified 47 specific gaps requiring remediation for HIPAA compliance
  • Prioritized findings by risk severity and compliance impact
2
Security Program Design

Weeks 3-4

Based on assessment findings, we designed a comprehensive security program that addressed HIPAA requirements, SOC 2 Trust Service Criteria, and the unique needs of biotech research operations.

  • Developed 22 security policies covering all HIPAA administrative safeguards
  • Designed technical architecture for network segmentation and access controls
  • Created data classification framework for PHI, research data, and IP
  • Established vendor risk management process with BAA templates
  • Defined security roles and responsibilities across the organization
  • Built a compliance monitoring dashboard for ongoing visibility
3
Technical Implementation

Weeks 5-8

We deployed the technical controls necessary to meet both HIPAA and SOC 2 requirements, working closely with the IT team to minimize disruption to research operations.

  • Deployed endpoint detection and response (EDR) across all workstations and servers
  • Implemented network segmentation isolating research, clinical, and corporate networks
  • Configured multi-factor authentication on all systems accessing PHI
  • Deployed email security with advanced phishing protection
  • Established encrypted backup system with offsite replication and tested recovery
  • Implemented SIEM for centralized logging and real-time threat detection
4
Training & Compliance Documentation

Weeks 9-11

We launched a company-wide security awareness program and finalized all documentation required for HIPAA compliance and SOC 2 audit readiness.

  • Delivered role-based security awareness training to all 200 employees
  • Conducted department-specific HIPAA training for teams handling PHI
  • Launched ongoing phishing simulation program with monthly exercises
  • Compiled complete HIPAA compliance documentation package
  • Prepared SOC 2 Type I evidence collection and control matrix
  • Coordinated with external auditor for SOC 2 Type I examination
5
Validation & Certification

Weeks 11-13

We validated all controls through internal testing, supported the SOC 2 audit, and ensured the organization was prepared for ongoing compliance maintenance.

  • Conducted internal audit of all HIPAA safeguards and controls
  • Supported external SOC 2 Type I audit with evidence and explanations
  • Performed penetration testing to validate technical controls
  • Remediated two minor findings identified during the SOC 2 audit
  • Established ongoing monitoring and quarterly review cadence
  • Transitioned to managed detection and response for continuous protection

Implementation Details

The technical implementation required careful coordination with the company’s research operations. We scheduled deployments during off-hours when possible and used phased rollouts to minimize disruption to active research projects.

Network segmentation was the most complex undertaking. We divided the flat corporate network into four distinct zones: research, clinical data, corporate operations, and guest access. Each zone received tailored security controls and monitoring appropriate to the sensitivity of data it handled.

The SIEM deployment provided centralized visibility across all network segments for the first time. Within the first week of operation, it identified three misconfigured cloud storage buckets that were publicly accessible -- a finding that underscored the urgency of the program.

For the SOC 2 audit, we worked with a nationally recognized audit firm experienced in biotech engagements. Our pre-audit preparation and organized evidence collection allowed the audit to be completed in just two weeks, compared to the typical 4-6 week timeline.

Results & Impact

90-Day

Timeline to Compliance

SOC 2

Type I Certified

60%

Fewer Security Incidents

3

New Enterprise Partnerships

The company achieved full HIPAA compliance within the 90-day target, with all administrative, technical, and physical safeguards documented and implemented. The SOC 2 Type I audit was completed with zero critical findings and only two minor observations that were remediated during the audit period.

With compliance certifications in hand, the company executed both partnership agreements and secured a third partnership that had been contingent on demonstrating a mature security posture. The combined contract value exceeded initial projections.

In the six months following implementation, the company saw a 60% reduction in security incidents compared to the six months prior. The phishing simulation program reduced click rates from 34% to under 8%, and the MDR platform identified and contained three legitimate threats that would have previously gone undetected.

Lessons Learned

Executive Sponsorship Accelerates Everything

Having the CEO champion the security program from day one removed organizational friction. When compliance is positioned as a business enabler rather than an IT burden, teams cooperate rather than resist. The CEO communicated directly to all staff why this mattered for the company's growth.

Start with Data Mapping

Understanding where sensitive data lives and how it flows through the organization is the foundation of any compliance effort. The initial data mapping exercise revealed PHI in three systems that IT was not aware of, including a legacy research database and a shared cloud storage folder.

Parallel Workstreams Save Time

By running policy development, technical implementation, and training in parallel rather than sequentially, we compressed what typically takes 6-9 months into 90 days. This required careful coordination but was achievable with dedicated project management.

Compliance Is a Starting Point, Not the Finish Line

Achieving HIPAA compliance and SOC 2 certification is not the same as being secure. We designed the program to exceed minimum compliance requirements, which is why the organization saw a 60% reduction in security incidents rather than simply passing an audit.

Related Case Study

Defense / Government Contracting

Defense Contractor Prevents Ransomware Attack

4-hour containment, zero data loss, and CMMC Level 2 certification.

Need HIPAA Compliance for Your Biotech?

Start with a free gap assessment. Our San Diego team will evaluate your current security posture and build a roadmap to compliance.